/images/ppid_59c68470-image-176595516246794390.webp)
/images/ppid_59c68470-image-176586754381213259.webp)
What is the story about?
Shares of Royal Orchid Hotels Ltd
are trading with gains on Wednesday, December 17, after the company said it has signed a 43-room hotel in Baddi, Himachal Pradesh, marking its entry into one of North India’s key industrial clusters.
In an exchange filing, the company said the property named Regenta Place Golden Castle, will be managed under a management contract, in line with Royal Orchid’s asset-light expansion strategy. Although, financial details of the agreement were not disclosed.
The hospitality company said Baddi is known as Asia’s largest pharmaceutical manufacturing hub and has a steady flow of corporate and industrial travel. Arjun Baljee, President, Royal Orchid & Regenta Hotels said, "Baddi's status as a major industrial and pharmaceutical hub makes it a key market for our
business traveler segment."
He added that the signing "reinforces our strategy to establish a reliable, high-quality presence in important regional centers across North India," tapping business travel demand while also catering to social and event-led bookings in the region.
The hotel, located on the Baddi–Nalagarh Road (NH-105), will feature 43 rooms across multiple categories, along with a restaurant, rooftop bar, banquet and meeting facilities, and outdoor event space. The property is expected to strengthen Royal Orchid’s presence in North India, where the group has been selectively adding managed properties.
Royal Orchid Hotels currently operates over 119 hotels in India and overseas across its Royal Orchid and Regenta brands. The company has been focusing on management-led growth to scale its portfolio without adding significant balance-sheet risk.
Shares of Royal Orchid Hotels were trading 2.22% up at ₹388.80 on the NSE at 11:18 am. The stock has fallen 10.59% in the last one month.
In an exchange filing, the company said the property named Regenta Place Golden Castle, will be managed under a management contract, in line with Royal Orchid’s asset-light expansion strategy. Although, financial details of the agreement were not disclosed.
The hospitality company said Baddi is known as Asia’s largest pharmaceutical manufacturing hub and has a steady flow of corporate and industrial travel. Arjun Baljee, President, Royal Orchid & Regenta Hotels said, "Baddi's status as a major industrial and pharmaceutical hub makes it a key market for our
business traveler segment."
He added that the signing "reinforces our strategy to establish a reliable, high-quality presence in important regional centers across North India," tapping business travel demand while also catering to social and event-led bookings in the region.
The hotel, located on the Baddi–Nalagarh Road (NH-105), will feature 43 rooms across multiple categories, along with a restaurant, rooftop bar, banquet and meeting facilities, and outdoor event space. The property is expected to strengthen Royal Orchid’s presence in North India, where the group has been selectively adding managed properties.
Royal Orchid Hotels currently operates over 119 hotels in India and overseas across its Royal Orchid and Regenta brands. The company has been focusing on management-led growth to scale its portfolio without adding significant balance-sheet risk.
Shares of Royal Orchid Hotels were trading 2.22% up at ₹388.80 on the NSE at 11:18 am. The stock has fallen 10.59% in the last one month.
/images/ppid_59c68470-image-176594757445489589.webp)
/images/ppid_a911dc6a-image-17658042341631228.webp)
/images/ppid_59c68470-image-176579502658750015.webp)
/images/ppid_59c68470-image-176580754237988742.webp)
/images/ppid_59c68470-image-176590002721971315.webp)
